scholarly journals SP-0040 Exploiting IGRT to calculate delivered dose for normal tissue sparing

2019 ◽  
Vol 133 ◽  
pp. S12-S13
Author(s):  
L. Shelley
2009 ◽  
Vol 48 (2) ◽  
pp. 238-244 ◽  
Author(s):  
Jimmi Søndergaard ◽  
Morten Høyer ◽  
Jørgen B. Petersen ◽  
Pauliina Wright ◽  
Cai Grau ◽  
...  

2020 ◽  
Vol 25 (1) ◽  
pp. 85-90
Author(s):  
Barbara Melles-Bencsik ◽  
Tamás Pócza ◽  
Tibor Major ◽  
Péter Ágoston ◽  
Kliton Jorgo ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2578
Author(s):  
Mikaela Dell’Oro ◽  
Michala Short ◽  
Puthenparampil Wilson ◽  
Chia-Ho Hua ◽  
Melissa Gargone ◽  
...  

Background: Proton radiotherapy produces superior dose distributions compared to photon radiotherapy, reducing side effects. Differences between the two modalities are not fully quantified in paediatric patients for various intracranial tumour sites or age. Understanding these differences may help clinicians estimate the benefit and improve referral across available centres. Our aim was to compare intensity-modulated proton therapy (IMPT) and intensity-modulated photon radiotherapy (IMRT) radiation doses for select paediatric intracranial tumours. Methods: IMPT and IMRT dose distributions for gender-matched paediatric cranial CT-datasets (ages 5, 9 and 13 years) were retrospectively calculated to simulate irradiation of supratentorial (ependymoma) and infratentorial (medulloblastoma) target volumes diameters (1–3 cm) and position (central and 1–2 cm shifts). Results: Clinical dosimetric objectives were achieved for all 216 treatment plans. Whilst infratentorial IMPT plans achieved greater maximum dose sparing to optic structures (4.8–12.6 Gy optic chiasm), brainstem sparing was limited (~0.5 Gy). Mean dose difference for optic chiasm was associated with medulloblastoma target position (p < 0.0197). Supratentorial IMPT plans demonstrated greater dose reduction for the youngest patients (pituitary gland p < 0.001). Conclusions: Normal tissue sparing was achieved regardless of patient age for infratentorial tumours. However, for supratentorial tumours, there was a dosimetric advantage of IMPT across 9 vs. 13-year-old patients.


2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Omar Dawood ◽  
Colin Sims ◽  
John Dooley ◽  
Paul Meskell ◽  
Alan Katz ◽  
...  

2008 ◽  
Vol 47 (7) ◽  
pp. 1382-1389 ◽  
Author(s):  
Pauliina Wright ◽  
Anthony Thomas Redpath ◽  
Morten Høyer ◽  
Cai Grau ◽  
Ludvig Paul Muren

2006 ◽  
Vol 78 (3) ◽  
pp. 276-282 ◽  
Author(s):  
Claudio Fiorino ◽  
Italo Dell'Oca ◽  
Alessio Pierelli ◽  
Sara Broggi ◽  
Elena De Martin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document